Detecting hidden heart amyloidosis in atrial fibrillation patients
Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.
This study uses advanced heart scans and AI technology to find early signs of amyloidosis (a protein buildup in the heart) in people with atrial fibrillation. Catching it early may help prevent serious heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You have atrial fibrillation (irregular heartbeat) that comes and goes or is ongoing
- You have at least one warning sign, such as shortness of breath, swelling, fatigue, or chest discomfort
- You can have either a special AI heart scan or a CT scan to measure protein in your heart
- You have not been previously diagnosed with cardiac amyloidosis
- You do not have very severe heart failure or a terminal illness
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This trial uses an AI tool to analyze your heart's electrical signals (ECG) to better understand your risk of heart failure and how well your heart recovers after a procedure called catheter ablation for atrial fibrillation. It may help guide your treatment if you have early signs of heart failure.
This trial tests whether artificial intelligence can help doctors spot cardiac amyloidosis (a protein buildup in the heart) using heart ultrasound images. If you have signs of a thickened heart wall and possible amyloidosis, this study could help confirm your diagnosis faster and more accurately.
This trial uses an artificial intelligence system to analyze your electrocardiogram (ECG) results and alert your care team if you might be developing atrial fibrillation. It aims to catch this common heart rhythm problem early, so you can get treatment sooner.
This trial tests an AI program that looks at your heart ultrasound (echocardiogram) to find possible signs of cardiac amyloidosis early. It helps doctors decide if more testing is needed.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Hear when a new Cardiac Amyloidosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.